- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Fortis Healthcare reported robust Q4 & FY26 results. Consolidated revenue grew 17.8% (Q4) to INR2,365 Cr and 17.3% (FY26) to INR9,128 Cr. PAT surged 44.2% (Q4) and 31.5% (FY26). Hospital EBITDA margins hit 22.1% (Q4) and 22.2% (FY26). Management projects 15%+ hospital revenue growth and 150bps margin improvement for FY27. Diagnostics targets double-digit revenue growth and 23-24% EBITDA margins. While Q4 saw some occupancy dips due to international business and drug price caps, domestic growth and strategic expansions like new beds and acquisitions are driving confidence in sustained strong performance. Debt-to-EBITDA is 1.09x.